During the past decade, National Kyushu Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 6 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Kyushu Cancer Center" #1 sponsor was "Gynecologic Oncology Group" with 4 trials, followed by "Haruhiko Fukuda" with 4 trials sponsored, "National Cancer Institute (NCI)" with 2 trials sponsored, "GOG Foundation" with 1 trials sponsored and "Japan Clinical Oncology Group" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Kyushu Cancer Center" #1 collaborator was "Ministry of Health, Labour and Welfare, Japan" with 5 trials as a collaborator, "National Cancer Institute (NCI)" with 5 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "SWOG Cancer Research Network" with 1 trials as a collaborator and "Taiho Pharmaceutical Co., Ltd." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "National Kyushu Cancer Center" are "Adult Type Ovarian Granulosa Cell Tumor" (1 trials), "Atypical Endometrial Hyperplasia" (1 trials), "Clear Cell Adenocarcinoma" (1 trials), "Colorectal Neoplasms" (1 trials) and "Fallopian Tube Clear Cell Adenocarcinoma" (1 trials). Many other conditions were trialed in "National Kyushu Cancer Center" in a lesser frequency.

Most popular intervention types in "National Kyushu Cancer Center" are "Drug" (10 trials), "Other" (4 trials), "Biological" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (4 trials), "Paclitaxel" (4 trials), "Carboplatin" (3 trials), "Docetaxel" (2 trials) and "Quality-of-Life Assessment" (2 trials). Other intervention names were less common.

The vast majority of trials in "National Kyushu Cancer Center" are 8 trials for "Female" genders and 4 trials for "All" genders.

Currently, there are NaN active trials in "National Kyushu Cancer Center". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in National Kyushu Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in National Kyushu Cancer Center, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

National Kyushu Cancer Center has several departments that took part in Clinical trials: "Kitakyushu Municipal Medical Center, Surgery" - 2 trials